Intermezzo is indicated for the treatment of insomnia or sleeping disorders.
The refiling of the application follows a meeting between Transcept and the FDA, to discuss the issues raised by the FDA in July 2011 Complete Response Letter.
Intermezzo is indicated for the treatment of insomnia or sleeping disorders.
The refiling of the application follows a meeting between Transcept and the FDA, to discuss the issues raised by the FDA in July 2011 Complete Response Letter.